Hojjatollah Nozad Charoudeh | Immunotherapy | Best Researcher Award

Publication Profile

Orcid

Education 

Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh holds an impressive academic background in biomedical sciences and physiotherapy 🧬🧠. He completed his postdoctoral research in immunotherapy at the Biomedicine Department of Basel University, Switzerland (2010–2011) 🇨🇭. Prior to that, he earned his Ph.D. at the Stem Cell Center, Lund University, Sweden (2006–2010) 🇸🇪. His foundational medical education began in Iran, where he received an M.Sc. in Anatomy (1994–1997) and a B.Sc. in Physiotherapy (1988–1992) from Jundishapur University of Medical Sciences 🏥📚. His journey reflects a strong commitment to advancing medical knowledge and patient care globally 🌍💉.

Experience

Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh is a distinguished academic with a rich background in anatomical sciences and stem cell biology 🧬🧑‍🏫. Since 2025, he has been affiliated with the Scientific Center of Zoology and Hydroecology, NAS RA in Yerevan, Armenia 🇦🇲. From 2015 to 2023, he served as an Associate Professor in the Anatomical Sciences Department, and from 2014 to 2017, he led the Stem Cell Research Centre at Tabriz University of Medical Sciences 🇮🇷. His earlier roles include Assistant Professor (2012–2015) and Instructor (1998–2005). He is also an Associate Editor of Advanced Pharmaceutical Bulletin 📘🔬.

Thesis and Grants

Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh has led extensive research in immunotherapy and stem cell biology 🌱🧬. His work focuses on KIR⁺ NK cells from cord blood for cancer and leukemia treatment 🧫🎯, exploring telomere and mitochondrial inhibition in leukemia and breast cancer stem cells 🔬💥. He has supervised numerous Ph.D. and Master’s students 👩‍🎓👨‍🎓 across projects on PI3K/AKT signaling, NF-κB, TDT, and liver cell apoptosis pathways 🧠⚙️. His studies highlight the potential of CD34⁺ stem cells and gene regulation in immune therapies 💉🧪, contributing significantly to translational medicine and cancer immunotherapy advancements 🌍🏥.

Awards

Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh has built a distinguished academic career with numerous international and national achievements. He was awarded a Ph.D. scholarship by the Iranian Ministry of Health in 2006 🎓🇮🇷 and later received a six-month scientific grant at Lund University in 2009 🌍🔬. In 2010, he pursued postdoctoral research in the Immunotherapy Department at Basel University, Switzerland 🧪🇨🇭. He secured a research fund from Tabriz University of Medical Sciences in 2012 💼🔍 and received a prestigious EMBO short scholarship grant in 2013 🧬🌟. His journey reflects dedication to scientific excellence and global collaboration 🤝📚.

Research Focus

Assoc. Prof. Dr. Hojjatollah Nozad Charoudeh’s research primarily focuses on cancer biology, particularly the mechanisms of apoptosis and targeted therapies in hematologic and solid tumors. 🧬 His work explores how natural killer (NK) cells, telomerase inhibition, and mitochondrial targeting induce apoptosis in acute myeloid leukemia and breast cancer cells. 🔬 He also investigates histone deacetylase inhibitors and the role of Vitamin C in modulating cancer stem cell behavior under hypoxic conditions. 💊 His multidisciplinary approach bridges immunotherapy, molecular oncology, and drug design, aiming to enhance therapeutic efficacy and combat cancer resistance. 🧫🧪🧠 His studies integrate biochemistry, pharmacology, and cellular biology. 📚🧠

Publication Top Notes